On Thursday, in the course of Afternoon trade, Shares of Sprouts Farmers Market Inc (NASDAQ:SFM), climbed 0.05%, and is now trading at $20.92.
Sprouts Farmers Market, stated results for its 13-week second quarter ended June 28, 2015.
Second Quarter Highlights:
- Net sales of $902.2 million; a 21% enhance from the same period in 2014
- Comparable store sales growth of 5.1% and two-year comparable store sales growth of 14.6%
- Net income of $31.3 million and diluted earnings per share of $0.20
- Adjusted net income of $35.0 million; a 16% enhance from the same period in 2014
- Adjusted diluted earnings per share of $0.22; a 10% enhance from the same period in 2014
- Adjusted EBITDA of $77.6 million; a 12% enhance from the same period in 2014
- New $450 million revolving credit facility; $160 million outstanding after $100 million voluntary pay down
Sprouts Farmers Market, Inc. operates as a specialty retailer of fresh, natural, and organic food in the United States. The companys stores offer fresh produce, bulk foods, vitamins and supplements, grocery products, meat and seafood products, deli and bakery products, dairy and dairy alternatives, frozen foods, beer and wine, natural health and body care products, and natural household products.
During an Afternoon trade, Shares of Cablevision Systems Corporation (NYSE:CVC), dipped -0.76%, and is now trading at $24.90.
Cablevision Systems Corporation, stated financial results for the second quarter ended June 30, 2015.
Second quarter merged net revenues raised 1.6% to $1.653 billion, merged adjusted operating cash flow (“AOCF”) reduced 2.7% to $474.3 million and merged operating income reduced 4.5% to $244.5 million, all contrast with the preceding year period.
Operating highlights for the second quarter comprise:
- Improved subscriber performance with largest quarterly gains in both customer relationships and high-speed data, in more than two years.
- Average Monthly Cable Revenue per Customer (“RPC”) of $158.52, an enhance of $5.80 or 3.8%, contrast with the preceding year period.
- Year to date Merged Free Cash Flow from Ongoing Operations1 of $207.3 million.
Cablevision CEO James L. Dolan said, “Cablevision continued to perform well in the second quarter, achieving growth in net revenue and revenue per customer. Over the past three years, we have transformed our company through planned investments that have made our operations more efficient, raised the reliability and performance of our network, and improved our products and the customer experience. This has contributed to our largest quarterly gains in both customer relationships and high-speed data customers in more than two years. We will continue to focus on providing superior service and innovative products that will resonate with consumers.”
Cablevision Systems Corporation, together with its auxiliaries, owns and operates cable systems in the United States. The company operates through three segments: Cable, Lightpath, and Other.
Shares of Solaredge Technologies Inc (NASDAQ:SEDG), during its Thursday’s current trading session fell -1.63%, and is now trading at $24.76.
SolarEdge Technologies, declared administration of SolarEdge will take part in the Deutsche Bank Technology Conference on Thursday, September 17, 2015 in Las Vegas, NV.
SolarEdge Technologies, Inc. manufactures and supplies DC optimized inverter systems for solar PV installations. The company’s DC optimized inverter system comprises of power optimizers, inverters, and cloud-based monitoring software.
Finally, EXACT Sciences Corporation (NASDAQ:EXAS), lost -2.97% Thursday.
Exact Sciences Corp., declared that Cologuard was awarded a Wisconsin Innovation Award (WIA) in the “Healthcare/Health IT” category at the second annual ceremony held on August 18, 2015 at Discovery World in Milwaukee, Wisconsin. Cologuard was chosen from more than 170 entries and 33 finalists to receive one of 10 awards.
“Cologuard is an innovative test for the early detection of colon cancer that provides patients with an easy-to-use and noninvasive screening option,” said Kevin Conroy, Chairman and CEO of Exact Sciences. “The uniqueness of Cologuard is indicative of the creativity, ingenuity and partnershiptaking place throughout Wisconsin. We are honored to be recognized with this award and remain committed to achieving our mission of assisting eradicate colon cancer through early detection.”
Cologuard is the first and only FDA approved noninvasive stool DNA screening test for colorectal cancer. It detects the presence of cancer and precancer by analyzing both DNA and blood in the stool and offers people an easy-to-use screening test, which they can do in the privacy of their own home. Unlike other screening options, Cologuard does not require medication or dietary restrictions or bowel preparation preceding to taking the test. Cologuard is accessible by prescription only through a healthcare provider.
Exact Sciences Corporation, a molecular diagnostics company, focuses on developing non-invasive colorectal cancer screening products. The company develops the Cologuard, a non-invasive stool-based DNA colorectal cancer screening test that is designed to detect pre-cancerous lesions or polyps, and each of the four stages of colorectal cancer.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
